MILWAUKEE -- For many, flying in a plane can be a nerve-wracking experience. In fact, 1 in 6 people reports a fear so severe that it prevents them from flying entirely. But, for a handful of local Wisconsin Veterans, flying in an open-cockpit Stearman Biplane remained a lifelong dream. A dream they would soon achieve[...]
With the national rollout of the COVID-19 vaccine already underway, healthcare facilities nationwide are being faced with the challenge of balancing safety, documentation, and efficiency, in their protocols for vaccine distribution.
The ConsortiEX family is currently ramping up for the 2019 ASHP Midyear Clinical Meeting, but we want to take a moment to thank all of our customers for their continued partnership on our journey to improve patient outcomes, and in securing the pharmaceutical supply chain. We remain committed to providing health care[...]
We would like to thank all attendees of the ASHP Summer Meetings who stopped by to see us. Having the opportunity to discuss our compliance solutions, in-person, is one that we do not take for granted.
Since our foundation, ConsortiEX has aimed to deliver highly innovative IT systems for hospitals and their affiliated networks. A crucial part of that goal was a seamlessly integrated solution that would satisfy the need for both anticipatory batch and patient specific compounding. We have achieved this with our[...]
ConsortiEX will be shipping up to Boston for this year’s ASHP Summer Meeting. We encourage you to stop at Booth 201 for an in-person look at how you can use our intuitive DQSA Compliance solutions to enhance patient safety, ensure quality control and simplify your compliance needs.
Many hospitals struggle to achieve optimal compliance with the Drug Supply Chain Security Act (DSCSA). The challenge to comply seems to come from an incomplete or inaccurate understanding of the regulations, which is understandable given the Act’s complexity. DSCSA was put in place to protect consumers from harmful[...]
ConsortiEX is proud to announce T3 verification, the newest feature to be added to our DSCSA Compliance as a Service (CaaS) module. The T3 Verification process gives pharmacies maximum visibility to all T3 transactions, both electronic and paper, received by their pharmacy.
The FDA has issued a guidance to 503B facilities regarding Current Good Manufacturing Practice (gCMB)
The FDA recently issued a draft guidance regarding verification* systems in accordance with the Drug Supply Chain Security Act (DSCSA).